HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter Ellis Selected Research

interleukin-21 (interleukin 21)

4/2007Distinct cytokine-driven responses of activated blood gammadelta T cells: insights into unconventional T cell pleiotropy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter Ellis Research Topics

Disease

15Neoplasms (Cancer)
12/2023 - 09/2005
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2023 - 09/2005
4Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2023 - 05/2006
3Uterine Cervical Neoplasms (Cancer of the Cervix)
07/2022 - 09/2005
3Erectile Dysfunction
09/2010 - 01/2002
2Abdominal Aortic Aneurysm
01/2017 - 07/2014
2Respiratory Insufficiency (Respiratory Failure)
01/2017 - 07/2014
2Myocardial Infarction
01/2017 - 07/2014
2Stroke (Strokes)
01/2017 - 07/2014
2Neoplasm Metastasis (Metastasis)
01/2014 - 09/2009
2Lower Urinary Tract Symptoms
09/2010 - 09/2010
1Hypoxia (Hypoxemia)
11/2023
1Wounds and Injuries (Trauma)
03/2018
1Lymphatic Metastasis
11/2014
1Breast Neoplasms (Breast Cancer)
11/2014
1Aneurysm (Aneurysms)
07/2014
1Latent Tuberculosis
05/2014
1Disease Progression
01/2014
1Lung Neoplasms (Lung Cancer)
01/2014
1Pneumonia (Pneumonitis)
01/2014
1Inflammation (Inflammations)
01/2013
1Autoimmune Diseases (Autoimmune Disease)
03/2012
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2011
1Leukemia
05/2011
1Autoimmune Hepatitis
01/2011
1Overactive Urinary Bladder (Overactive Bladder)
09/2010
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
09/2010
1Nocturia
09/2010
1Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
10/2009
1Autistic Disorder (Autism)
10/2009
1Prostatic Neoplasms (Prostate Cancer)
09/2009
1Virus Diseases (Viral Diseases)
07/2009
1Premature Birth (Birth, Premature)
07/2009
1Sarcoma (Soft Tissue Sarcoma)
01/2009
1Exanthema (Rash)
09/2007
1Infections
04/2007
1Communicable Diseases (Infectious Diseases)
04/2007
1Chromosome Aberrations (Chromosome Abnormalities)
01/2007
1Malignant Mesothelioma
07/2006

Drug/Important Bio-Agent (IBA)

3Biomarkers (Surrogate Marker)IBA
12/2023 - 01/2009
2Messenger RNA (mRNA)IBA
11/2014 - 10/2009
2Phosphodiesterase 5 InhibitorsIBA
09/2010 - 09/2010
21- (6- ethoxy- 5- (3- ethyl- 6,7- dihydro- 2- (2- methoxyethyl)- 7- oxo- 2H- pyrazolo(4,3- d)pyrimidin- 5- yl)- 3- pyridyl sulphonyl)-4-ethylpiperazineIBA
09/2010 - 09/2010
2DNA (Deoxyribonucleic Acid)IBA
10/2009 - 01/2009
2VaccinesIBA
01/2009 - 09/2005
2Cisplatin (Platino)FDA LinkGeneric
07/2006 - 05/2006
1Protein Kinases (Protein Kinase)IBA
11/2023
1Adenosine Monophosphate (AMP)IBA
11/2023
1CanagliflozinIBA
11/2023
1cyclopropapyrroloindoleIBA
06/2019
1SmokeIBA
03/2018
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2018
1Immune Checkpoint InhibitorsIBA
11/2017
1Proteins (Proteins, Gene)FDA Link
11/2014
1Isoniazid (Ftivazide)FDA LinkGeneric
05/2014
1L-BLP25IBA
01/2014
1LipopeptidesIBA
01/2014
1AntigensIBA
01/2014
1Trastuzumab (Herceptin)FDA Link
01/2013
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
03/2012
1P-2 (P 2)IBA
03/2012
1NucleophosminIBA
05/2011
1nuclear pore complex protein 98IBA
05/2011
1Immunoglobulin M (IgM)IBA
01/2011
1TransposasesIBA
11/2010
1Oxytocin Receptors (Oxytocin Receptor)IBA
10/2009
1hydrogen sulfite (bisulfite)IBA
10/2009
1Oxytocin (Pitocin)FDA LinkGeneric
10/2009
1GTI2040IBA
09/2009
1Docetaxel (Taxotere)FDA Link
09/2009
1Hormones (Hormone)IBA
09/2009
1PlatinumIBA
09/2009
1Prostate-Specific Antigen (Semenogelase)IBA
09/2009
1CytokinesIBA
07/2009
1Toll-Like Receptor AgonistsIBA
07/2009
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2009
1Interleukin-2 (IL2)IBA
07/2009
1vandetanib (ZD6474)IBA
09/2007
1Epidermal Growth Factor (EGF)IBA
09/2007
1Chemokine CXCL13IBA
04/2007
1interleukin-21 (interleukin 21)IBA
04/2007
14-hydroxy-3-methylbut-2-enyl pyrophosphateIBA
04/2007
14-hydroxy-3-methyl-2-butenyl diphosphateIBA
04/2007
1A 7 (A-7)IBA
01/2007
1Pemetrexed (MTA)FDA Link
07/2006
1Irinotecan (Camptosar)FDA LinkGeneric
05/2006

Therapy/Procedure

8Therapeutics
12/2023 - 09/2007
3Radiotherapy
11/2023 - 09/2007
3Palliative Care (Palliative Therapy)
01/2023 - 03/2015
2Immunotherapy
06/2019 - 01/2014
2Endovascular Aneurysm Repair
01/2017 - 07/2014
2Surgical Amputation (Amputations)
01/2017 - 07/2014
2Drug Therapy (Chemotherapy)
09/2009 - 07/2006
1Brachytherapy
01/2023
1Activities of Daily Living (ADL)
07/2022
1Endovascular Procedures
07/2014
1Injections
01/2014
1Chemoradiotherapy
01/2014
1Intravenous Infusions
09/2009
1Induction Chemotherapy
09/2007